Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Van Le

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Obstetrics and Gynecology|December 24, 2008
Stage IC ovarian cancer: the clinical significance of intraoperative ruptureLinda Van Le
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation ToxicityLinda Van Le, Mary McCormack
Obstetrical & Gynecological Survey|July 29, 2011
Chemotherapy for gynecologic cancers occurring during pregnancyEmily M Ko, Linda Van Le
Obstetrical & Gynecological Survey|December 18, 2015
Enhanced Recovery Pathways in Gynecology and Gynecologic OncologyEmma L Barber, Linda Van Le
Gynecologic Oncology|August 21, 2003
Gemcitabine as a single-agent treatment for ovarian cancerWesley C Fowler, Linda Van Le
Obstetrical & Gynecological Survey|September 24, 2009
Carcinosarcoma of the ovary a reviewLeigh A Cantrell, Linda Van Le
Obstetrical & Gynecological Survey|January 17, 2019
A Review of Gynecologic Oncology in the Global Setting: Educating and Training the Next Generation of Women's Health ProvidersStephanie A Sullivan, Elizabeth Stringer, Linda Van Le
Cancer|March 8, 2011
The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survivalLeigh A Cantrell, Shannon N Westin, Linda Van Le
Obstetrics and Gynecology|August 5, 2004
The clinical significance of a negative loop electrosurgical cone biopsy for high-grade dysplasiaChad A Livasy, Dominic T Moore, Linda Van Le
Obstetrics and Gynecology|March 3, 2004
High-grade squamous intraepithelial lesions: abbreviating posttreatment surveillanceElizabeth N Skinner, Paola A Gehrig, Linda Van Le
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Obstetrics and Gynecology|December 24, 2008
Stage IC ovarian cancer: the clinical significance of intraoperative ruptureLinda Van Le
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation ToxicityLinda Van Le, Mary McCormack
Obstetrical & Gynecological Survey|July 29, 2011
Chemotherapy for gynecologic cancers occurring during pregnancyEmily M Ko, Linda Van Le
Obstetrical & Gynecological Survey|December 18, 2015
Enhanced Recovery Pathways in Gynecology and Gynecologic OncologyEmma L Barber, Linda Van Le
Gynecologic Oncology|August 21, 2003
Gemcitabine as a single-agent treatment for ovarian cancerWesley C Fowler, Linda Van Le
Obstetrical & Gynecological Survey|September 24, 2009
Carcinosarcoma of the ovary a reviewLeigh A Cantrell, Linda Van Le
Obstetrical & Gynecological Survey|January 17, 2019
A Review of Gynecologic Oncology in the Global Setting: Educating and Training the Next Generation of Women's Health ProvidersStephanie A Sullivan, Elizabeth Stringer, Linda Van Le
Cancer|March 8, 2011
The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survivalLeigh A Cantrell, Shannon N Westin, Linda Van Le
Obstetrics and Gynecology|August 5, 2004
The clinical significance of a negative loop electrosurgical cone biopsy for high-grade dysplasiaChad A Livasy, Dominic T Moore, Linda Van Le
Obstetrics and Gynecology|March 3, 2004
High-grade squamous intraepithelial lesions: abbreviating posttreatment surveillanceElizabeth N Skinner, Paola A Gehrig, Linda Van Le
Pageof 7